bhwords Profile Banner
Professor Beverley Hunt OBE (also on BlueSky) Profile
Professor Beverley Hunt OBE (also on BlueSky)

@bhwords

Followers
10K
Following
14K
Media
755
Statuses
6K

Passionate about thrombosis & bleeding care. Founder of Thrombosis UK but views are my own. Crazed cyclist.

Joined August 2012
Don't wanna be here? Send us removal request.
@TomReiser
Thomas Reiser
4 days
Join the🗓️Nov. 13 @ISTH webinar on the role of viscoelastic testing in fibrinolytic disorders 🎙️P. Collins 🇬🇧 & J. Brogaard Larsen 🇩🇰 discuss eval. fibrinolysis through viscoelastic testing & provide a clin. appl. focusing on acute obstetric coagulopathy. https://t.co/HTJsxHfTO1
0
2
4
@HemostasisToday
Hemostasis Today
27 days
Caroline Dixon and Colleagues on LMWH Dosing to Reduce The Risk of VTE in Pregnant Women With Inherited ATD @JTHjournal @bhwords https://t.co/IR8aHlQNrt #AntithrombinDeficiency #AT #ATD #Health #MedEd #Hematology #Hemostasis #HemostasisToday #JTH #LMWH #Medicine #Pregnancy
0
3
7
@TomReiser
Thomas Reiser
29 days
🚨Tomorrow is #WorldThrombosisDay🚨 🎧to the latest @isth Pulse Podcast w/Lai Heng Lee 🇸🇬 & @bhwords 🇬🇧 as they share global insights on hospital-associated #VTE prevention, highlight gaps in care, & explore opport. for improvement #WTDay25 @thrombosisday https://t.co/amzwNC4teG
0
6
14
@PathologyRCPA
The Royal College of Pathologists of Australasia
1 month
New episode of The #Pathology Report is out now 🎧 Tune in to hear A/Prof Dan Owens explore the latest on managing bleeding with Prof Beverley Hunt and Dr Pratheepan Puvanakumar @bhwords @do315 https://t.co/iJqDhEetAj
0
2
3
@PERTConsortium
The PERT Consortium®
2 months
Common myths of LMWH vs UFH use highlighted by @bhwords along with advice on leveraging the unique qualities of each agent for each clinical scenario! #PERT2025 #PERTtrainee
0
7
13
@KSanfilippoMD
Kristen Sanfilippo
2 months
Shematology session in order! Different PERTs for different PEEPs. Tackling pregnancy, peds, cancer and athletics! @PERTConsortium #PERT2025 @bhwords @RosovskyRachel @AyeshaNZia
0
2
10
@bhwords
Professor Beverley Hunt OBE (also on BlueSky)
2 months
A meeting for everyone managing women with refractory obstetric APS, just sign up via Thrombosis UK website under calendar of events - it is free!
0
3
12
@SJaglin
Stephane Jaglin
3 months
Fantastic learning platform on all #VTE matters, set up by @ThrombosisUK @bhwords @EuropeanTHA @thrombosisday @SarahGreenLD https://t.co/FzQmOLjOPt
0
3
9
@l_cmurphy
Lauren Murphy
3 months
🚨 New paper alert! 🚨 I’m thrilled and proud to share that our latest work has just been published in @ScienceMagazine! 🎉 🧽 📖 Read our paper here: https://t.co/CvYSNq2nHj 🎬 Watch a summary: https://t.co/qvuZR3reTj 🧵 Or keep reading for the key points! 🔑 1/19
1
30
77
@PERTConsortium
The PERT Consortium®
4 months
We’re excited to share enrollment for HI-PEITHO is now complete! With 544 patients enrolled across 72 sites in the United States in Europe, this landmark trial compares EKOS (Ultrasound Assisted Thrombolysis) with Anticoagulation vs Anticoagulation Alone in the treatment of
1
11
22
@bhwords
Professor Beverley Hunt OBE (also on BlueSky)
4 months
Are anti-Platelet Factor 4 antibodies a cause of recurrent miscarriages??
@AnandPheresisMD
Anand Padmanabhan
4 months
Enjoyed this wonderful collaboration between @MayoClinic @MayoClinicPath and @UTSWMedCenter More studies are needed to evaluate this potential link!!
0
0
4
@katmayger
Kasia Mayger
5 months
Antithrombin has multiple effects haemostatically but is it involved in inflammatory pathways? Find out in this paper from @bhwords @katmayger & @Rui_Leite_ https://t.co/WeCExQgUKr
0
2
2
@KJClots
Katherine Creeper
5 months
The best thing about #ISTH2025 is catching up with old friends and colleagues. @bhwords @doyley1_
0
2
11
@MaryCushmanMD
Mary Cushman 🫀🧠🩸
5 months
Is this the end of rivaroxaban for acute VTE? @LanaCastellucci presenting the COBBRA trial - 1st RCT comparing apixaban to riva over 3 months. 56% reduction in bleeding risk with apixaban. A safer Rx with the same efficacy. #ISTH2025
10
125
356
@RosovskyRachel
Rachel Rosovsky
5 months
We want to learn from you! How do you evaluate heavy menstrual bleeding in patients on anticoagulation. Take our survey: https://t.co/v8FTEuXHv9 @CardioNerds @isth @ASH_hematology @PERTConsortium @thrombosisday @acweyand @bhwords @aswolberg @fnainle
@RosovskyRachel
Rachel Rosovsky
7 months
How do you as a medical provider evaluate heavy menstrual bleeding in patients on anticoagulation? Foundation for Women & Girls w/Blood Disorders is interested in identifying ways to improve care for patients with menorrhagia through research survey.
0
5
8
@bhwords
Professor Beverley Hunt OBE (also on BlueSky)
6 months
Great news for ⁦⁦cTTP patients! ⁩ ⁩ MHRA approves first UK treatment for congenital thrombotic thrombocytopenic purpura (cTTP)  - https://t.co/Onkzjnidit
Tweet card summary image
gov.uk
As with all products, the MHRA will keep its safety under close review.
0
0
5
@ThrombosisUK
Thrombosis UK
6 months
09:30 BST - #NTW25: Join @bhwords discussing 'Improving VTE prevention in pregnancy & the puerperium' with presentations shared at yesterday's @
tuk-edu.vfairs.com
0
1
6
@ThrombosisUK
Thrombosis UK
6 months
09:30 BST - #NTW25: Join @bhwords discussing 'Improving VTE prevention in pregnancy & the puerperium' with presentations shared at yesterday's @BMFMSNews annual conference.
0
1
4
@RajangamAkshaya
Akshaya Rajangam
6 months
Continuing on in the same talk - lots of food for thought. We all use AES for thromboprophylaxis - but is it truly effective? What's the evidence? Excited for the UK study to uncover more insight into this. #BMFMS2025 @bhwords @BMFMSNews
0
5
6
@NandaSurabhi
Surabhi Nanda
6 months
0
4
5